Abstract
Diabetes mellitus has been traditionally classified as Type 1 and Type 2 on the basis of several criteria that generally reflect either insulin deficiency or functional defects in insulin secretion. In this chapter, we propose a new classification diabetes based on age of onset, body mass index and biomarkers such as islet autoantibodies and DR HLA alleles. In the second part of this chapter, we briefly discuss some novel hypotheses on the possibility of β-cell regeneration in diabetes in relation to the islet pathology of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Orsi CM, Hale DE, Lynch JL. Pediatric obesity epidemiology. Curr Opin Endocrinol Diabetes Obes 2011; 18:14–22.
Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2:1279–83.
Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 1981 Dec 19–26; 2(8260–61):1363–5.
Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev 2005; 204:232–49.
Srikanta S, Ricker AT, McCulloch DK et al. Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 1986; 35:139–42.
Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011; 57:168–75. Epub 2010 Dec 2.
Kawasaki E, Nakamura K, Kuriya G et al. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab 2010; 95:707–13. Epub 2010 Jan 8.
Orban T, Sosenko JM, Cuthbertson D et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009; 32:2269–74. Epub 2009 Sep 9.
Uibo R, Lernmark A. GAD65 autoimmunity-clinical studies. Adv Immunol 2008; 100:39–78.
Eisenbarth GS, Jeffrey J. The natural history of type 1A diabetes. Arq Bras Endocrinol Metabol 2008; 52:146–55.
Ismail D, Werther G. Persistent hyperinsulinaemic hypoglycaemia of infancy: 15 years’ experience at the Royal Children’s Hospital (RCH). Melbourne. J Pediatr Endocrinol Metab 2005; 18:1103–9.
Giurgea I, Bellanné-Chantelot C, Ribeiro M et al. Molecular mechanisms of neonatal hyperinsulinism. Horm Res 2006; 66:289–96. Epub 2006 Sep 26.
Christesen HB, Brusgaard K, Alm J et al. Rapid genetic analysis in congenital hyperinsulinism. Horm Res 2007; 67:184–8. Epub 2006 Nov 15.
Cherian MP, Abduljabbar MA. 14. Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): Long-term outcome following 95% pancreatectomy. J Pediatr Endocrinol Metab 2005; 18:1441–8.
Leibowitz G, Glaser B, Higazi AA et al. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 1995; 80:386–92.
Conget I, Sarri Y, Somoza N et al. Beta-cell function abnormalities in islets from an adult subject with nesidioblastosis and autoantibodies against the islet cells. Pancreas 1997; 14:71–5.
Nousia-Arvanitakis S, Galli-Tsinopoulou A, Dracoulacos D et al. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocrinol Metab 2000; 13: 319–24.
Pont A, Rubino JM, Bishop D. Diabetes mellitus and neuropathy following Vacor ingestion in man. Arch Intern Med 1979; 139:185–7.
Gumus P, Gomez R, Vargas A et al. The relationship of insulin secretion and GAD65 antibody levels at diagnosis on glycemic control in type 2 diabetes. J Pediatr Endocrinol Metab 2010; 23:1025–9.
Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem 2011; 57:176–85.
Borg H, Gottsäter A, Fernlund P et al. Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 1999; 10:142–6.
Borg H, Gottsäter A, Fernlund P et al. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51: 1754–62.
Jurgens CA, Toukatly MN, Fligner CL et al. β-Cell Loss and β-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid Deposition. Am J Pathol 2011; 178:2632–40.
.Rodríguez-Villar C, Conget I, Esmatjes E et al. Presence of markers predictive of type I pre-diabetes mellitus status in relatives of patients with type I diabetes mellitus. Med 1996; 107:371–4.
Luijf YM, Hermanides J, Serlie MJ et al. The added value of oral glucose tolerance testing in pre-diabetes. Curr Diabetes Rev 2011; 7:56–60.
Siljander HT, Veijola R, Reunanen A et al. Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia 2007; 50:2272–5.
Atkinson MA, Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes 2009; 16: 279–85.
In’t Veld P, Lievens D, De Grijse J et al. Screening for Insulitis in Adult Autoantibody-Positive Organ Donors Diabetes 2007; 56:2400–4.
Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619–33.
Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 1991; 165:97–103.
Rubio-Cabezas O, Klupa T, Malecki MT; CEED3 Consortium. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest 2011; 41:323–33.
Gianani R, Campbell-Thompson M, Sarkar SA et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 2010; 53:690–8.
Liggins C, Orlicky DJ, Bloomquist LA et al. Developmentally regulated expression of Survivin in human pancreatic islets. Pediatr Dev Pathol 2003; 6:392–7.
Hasel C, Bhanot UK, Heydrich R et al. Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFkappaB and IAPs. Lab Invest 2005; 85:1263–75.
Gianani R, Putnam A, Still T et al. Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 2006; 91:1855–61.
Jiang Y, Nishimura W, Devor-Henneman D et al. Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 2008; 57:2718–27.
Keenan HA, Sun JK, Levine J et al. Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59:2846–53.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Maulis, M., Gianani, R. (2013). β-Cell Regeneration in Human Pancreas. In: Ahmad, S.I. (eds) Diabetes. Advances in Experimental Medicine and Biology, vol 771. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5441-0_23
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5441-0_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5440-3
Online ISBN: 978-1-4614-5441-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)